Mazda Adli

8.9k citations
139 papers · 4.4k indexed · 1 hit paper · h-index 36
Topics
Treatment of Major Depression (55 papers)Bipolar Disorder and Treatment (48 papers)Tryptophan and brain disorders (20 papers)
Journals
The LancetSHILAP Revista de lepidopterologíaScientific Reports

In The Last Decade

Mazda Adli

129 papers receiving 4.2k citations

Hit Papers

Cities and Mental Health20172026202020232017100200300

Peers

Mazda Adli
Comparison fields: 5 of 159
  • Psychiatry and Mental health 1.6k
  • Pharmacology 1.3k
  • Experimental and Cognitive Psychology 839
  • Cognitive Neuroscience 743
  • Clinical Psychology 608
Replace Davangere P. Devanand with:
Davangere P. Devanand United States
Sérgio Machado Brazil
Molly E. Zimmerman United States
Wolnei Caumo Brazil
Yuping Ning China
Simone Reppermund Australia
Roderick K. Mahurin United States
Mark A. Demitrack United States
Edith Holsboer‐Trachsler Switzerland
J. Jolles Netherlands
Mazda Adli relative to Davangere P. Devanand United States Davangere P. Devanand's profile →
Citations per field
00.5×1.5×
Davangere P. Devanand · 1×
Citations per year

Countries citing papers authored by Mazda Adli

Since Specialization
Citations

This map shows the geographic impact of Mazda Adli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mazda Adli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mazda Adli more than expected).

Fields of papers citing papers by Mazda Adli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mazda Adli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mazda Adli. The network helps show where Mazda Adli may publish in the future.

Co-authorship network of co-authors of Mazda Adli

This figure shows the co-authorship network connecting the top 25 collaborators of Mazda Adli. A scholar is included among the top collaborators of Mazda Adli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mazda Adli. Mazda Adli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 26
2 1
3 3
4
SARS-CoV-2-Pandemie: Was lernen wir daraus für die Raumentwicklung?
0
5 6
6 13
7 33
8 7
9 11
10 30
11
Depression und Epilepsie: Zwei Krankheitsbilder mit gemeinsamen Ursachen?
1
12 18
13 29
14 18
15
A comparison on quality of life in unilateral transfemoral amputees who use either intelligent or simple mechanical knee joint.
1
16 14
17 223
18 41
19 29
20 15

About Mazda Adli

Mazda Adli is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Pharmacology, having authored 139 papers that have together received 4.4k indexed citations. Recurring topics across this work include Treatment of Major Depression (55 papers), Bipolar Disorder and Treatment (48 papers) and Tryptophan and brain disorders (20 papers). The work is most often cited by research in Biological Psychiatry (544 citations), Psychiatry and Mental health (1.6k citations) and Pharmacology (1.3k citations). Mazda Adli has collaborated with scholars based in Germany, United States and Türkiye. Frequent co-authors include Michael Bauer, Andreas Heinz, Tom Bschor, Erhan Akdoğan, Roland Ricken, Peter Schlattmann, Peter Brieger, Michael A. Rapp, Florian Seemüller and Oliver Gruebner. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026